NEPH · Nephros Inc
United States · RS rating 37 · As of 2026-11-03
| Price | 3.24 USD |
|---|---|
| 1-day change | +0.0% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 38 / 47 / 25 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 14 / 5 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -0.7% |
| Distance from 52-week high | +44.0% |
| Market cap (USD) | $30.2M |